Company Description
Coeptis Therapeutics Holdings (NASDAQ: ZSQR) is a publicly traded software - infrastructure company in the Technology sector. The company has a market capitalization of $773.8M, ranking #3,129 among all listed U.S. companies by market cap.
ZSQR stock has gained 5.0% over the past year. Shares last traded at $15.96.
This page provides a comprehensive overview of ZSQR stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Coeptis Therapeutics Holdings (ZSQR) stock last traded at $15.96, down 9.46% from the previous close. Over the past 12 months, the stock has gained 5.0%. At a market capitalization of $773.8M, ZSQR is classified as a small-cap stock with approximately 51.5M shares outstanding.
ZSQR Rankings
Latest News
Coeptis Therapeutics Holdings has 5 recent news articles, with the latest published 2 days ago. Of the recent coverage, 2 articles coincided with positive price movement and 1 with negative movement. Key topics include acquisition, AI. View all ZSQR news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
ZSQR Company Profile & Sector Positioning
Coeptis Therapeutics Holdings (ZSQR) operates in the Software - Infrastructure industry within the broader Technology sector and is listed on the NASDAQ.